BIO CEO & Investor Conference
Now in its 21st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities. Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, BIO One-on-One Partnering meetings, and networking opportunities.
BIA members receive $250 off the non-member registration rate. In addition to the standard $250 off non-member registration code for members, we are also offering a Special Delegation Offering for groups that have 5 or more in attendance.
Please contact email@example.com to learn more about the BIO’s Delegation Pricing and additional questions.